[Lieyun Network (WeChat:ilieyun
) Beijing] Reported on September 30
Lieyun Network recently learned that Delta Medical, a developer of orthopedic surgical instruments and rehabilitation medical devices, announced the completion of its Series D financing round, raising over RMB 100 million. The round was led by GL Ventures, with participation from Qiming Venture Partners, YuanBio Venture Capital, and Boxing Capital.
Li Jianbo, founder of Delta Medical, stated: “The sports medicine sector is currently highly favored by investment institutions, particularly in the area of domestic substitution, which holds immense growth potential. Delta Medical has established a robust industrial foundation in both R&D and manufacturing as well as marketing and sales, which represents the team’s most compelling advantage to investors.”
According to information from the Tianyancha app, Beijing Delta United Medical Technology Co., Ltd. was established in July 2016, with Li Jianbo serving as its legal representative. Li Jianbo, founder of Delta Medical, has been engaged in the sports medicine industry since obtaining his master’s degree in 2008, accumulating nearly a decade of industry experience. He has participated in and witnessed the growth of several major imported brands of arthroscopic consumables and surgical instruments, while also identifying market opportunities for domestic brands. Delta Medical boasts a young and dynamic R&D team, bringing together experts from various fields including clinical medicine, mechanical design, process engineering, bioengineering, and material applications. The company is dedicated to R&D, striving for perfection, and continuously learning and exploring advanced international design concepts and manufacturing processes. Adhering to an approach that integrates diverse strengths and focuses on customized development, Delta Medical designs efficient and user-friendly surgical instruments that directly enhance surgical efficiency and improve final outcomes, providing comprehensive end-to-end solutions for clinical practice. Currently, multiple products have been deployed in clinical settings, and the company has secured dozens of invention patents and provincial/municipal awards.
Delta Medical has established high-quality, high-efficiency modern production bases and R&D centers in Beijing, Sichuan, and Liaoning. Its product portfolio covers implantable consumables, surgical instruments, medical equipment, and rehabilitation braces, meeting the needs for both arthroscopic and open surgeries for common and frequently occurring conditions in sports medicine. The company strictly implements quality control procedures across all stages, including raw material procurement, processing technology, manufacturing processes, and surface treatment, ensuring that every product is safely and effectively used in surgical procedures.
Currently, Delta Medical has established collaborations with over 500 institutions both domestically and internationally. Its products have not only covered all provinces and cities across China but also entered into strategic partnerships with countries such as Japan, South Korea, Singapore, Germany, Canada, and Indonesia, laying the foundation for Chinese-made sports medicine brands to expand into overseas markets.